FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 316:715-718 March 19, 1987 Number 12 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We studied 40 women in the third trimester of pregnancy to determine whether alterations in serum calcium levels or in urinary calcium excretion would distinguish patients with preeclampsia from normal pregnant women or women with other forms of gestational hypertension. Our population included 10 normal pregnant women, 5 pregnant women with transient hypertension, 6 with chronic hypertension, 7 with chronic hypertension and superimposed preeclampsia, and 12 with preeclampsia. The serum levels of ionized calcium, phosphate, and 1,25-dihydroxyvitamin D were not different among the various groups. In contrast, the mean (+/- SD) 24-hour urinary calcium excretion in the patients with preeclampsia or hypertension with superimposed preeclampsia was significantly lower (42 +/- 29 and 78 +/- 49 mg) than that in normal pregnant women (313 +/- 140 mg per 24 hours), women with transient hypertension (248 +/- 139 mg per 24 hours), or women with chronic hypertension (223 +/- 41 mg per 24 hours) (P less than 0.0001). The hypocalciuria in the women with preeclampsia was associated with a decreased fractional excretion of calcium. Although the mean creatinine clearance was reduced in the women with preeclampsia, the range of values overlapped with those in the other groups. In contrast, we observed little or no overlap with respect to calcium excretion. We conclude that preeclampsia is associated with hypocalciuria due to increased tubular reabsorption of calcium. Measurement of calcium excretion may be useful in distinguishing preeclampsia from other forms of gestational hypertension.

This article has been cited by other articles:

• Seely, E. W. (2007). Calciotropic Hormones in Preeclampsia: A Renewal of Interest. J. Clin. Endocrinol. Metab. 92: 3402-3403 [Full Text]  
• Yang, Q., Wen, S. W., Smith, G. N, Chen, Y., Krewski, D., Chen, X. K., Walker, M. C (2006). Maternal cigarette smoking and the risk of pregnancy-induced hypertension and eclampsia. Int J Epidemiol 35: 288-293 [Abstract] [Full Text]  
• Thadhani, R., Mutter, W. P., Wolf, M., Levine, R. J., Taylor, R. N., Sukhatme, V. P., Ecker, J., Karumanchi, S. A. (2004). First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia. J. Clin. Endocrinol. Metab. 89: 770-775 [Abstract] [Full Text]  
• Villar, J., Merialdi, M., Gulmezoglu, A. M., Abalos, E., Carroli, G., Kulier, R., de Onis, M. (2003). Nutritional Interventions during Pregnancy for the Prevention or Treatment of Maternal Morbidity and Preterm Delivery: An Overview of Randomized Controlled Trials. J. Nutr. 133: 1606S-1625 [Abstract] [Full Text]  
• Ritchie, L. D, King, J. C (2000). Dietary calcium and pregnancy-induced hypertension: is there a relation?. Am. J. Clin. Nutr. 71: 1371S-1374 [Abstract] [Full Text]  
• Roberts, J. M. (1997). Prevention or Early Treatment of Preeclampsia. NEJM 337: 124-125 [Full Text]  
• Pipkin, F B. (1995). Fortnightly Review: The hypertensive disorders of pregnancy. BMJ 311: 609-613 [Abstract] [Full Text]